Am. J. Respir. Crit. Care Med., Volume 164, Number 4, August 2001, 597-601

Marked Sympathetic Activation in Patients with Chronic Respiratory Failure

SILKE HEINDL, MATTHIAS LEHNERT, CARL-PETER CRIÉE, GERD HASENFUSS, and STEFAN ANDREAS

Department of Cardiology and Pneumology, Georg-August-University, Göttingen, Germany; Department of Internal Medicine I, Medical University of Lübeck, Lübeck, Germany; and Department of Pneumology, Hospital Göttingen-Weende/Lenglern, Göttingen, Germany

The autonomic nervous system may be disturbed in chronic respiratory failure. We tested the hypothesis that there is increased sympathetic activity in patients with chronic hypoxemia. Furthermore, we examined the effect of short-term oxygen on muscle sympathetic nerve activity (MSNA) in these patients. We performed microneurography of the peroneal nerve in 11 patients with hypoxemia due to chronic obstructive pulmonary disease (COPD, n = 6) or lung fibrosis (n = 5) and in 11 healthy subjects matched for age and sex. MSNA was measured during normal breathing in all subjects. In eight patients and in seven control subjects, MSNA was also measured during nasal oxygen (4 L/min). MSNA was higher in the patients with chronic respiratory failure compared with the healthy subjects during normal breathing (61 ± 5 versus 34 ± 2 bursts/min, mean ± SEM; p = 0.0002, paired t test). During oxygen administration, MSNA decreased from 63 ± 6 to 56 ± 6 bursts/min in the patients (p = 0.0004, ANOVA); there was no change in sympathetic activity in the control subjects. For the first time, there is direct evidence of marked sympathetic activation in patients with chronic respiratory failure. This is partly explained by arterial chemoreflex activation and may play an important role in the pathogenesis of the disease.

Keywords: autonomic nervous system; respiration failure; microneurography; oxygen

This article has been cited by other articles:

				G. R. Chiappa, A. Borghi-Silva, L. F. Ferreira, C. Carrascosa, C. C. Oliveira, J. Maia, A. C. Gimenes, F. Queiroga Jr, D. Berton, E. M. V. Ferreira, et al. Kinetics of muscle deoxygenation are accelerated at the onset of heavy-intensity exercise in patients with COPD: relationship to central cardiovascular dynamics J Appl Physiol, May 1, 2008; 104(5): 1341 - 1350. [Abstract] [Full Text] [PDF]

				A. Boussuges and M. Gouitaa Arterial Stiffness and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 929 - 929. [Full Text] [PDF]

				C. Lundby, R. Boushel, P. Robach, K. Moller, B. Saltin, and J. A. L. Calbet During hypoxic exercise some vasoconstriction is needed to match O2 delivery with O2 demand at the microcirculatory level J. Physiol., January 1, 2008; 586(1): 123 - 130. [Abstract] [Full Text] [PDF]

				D. D. Sin and S. F. P. Man Pharmacotherapy for Mortality Reduction in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, September 1, 2006; 3(7): 624 - 629. [Abstract] [Full Text] [PDF]

				B. J. Canning Reflex regulation of airway smooth muscle tone J Appl Physiol, September 1, 2006; 101(3): 971 - 985. [Abstract] [Full Text] [PDF]

				E. J. Oh, S. B. Mazzone, B. J. Canning, and D. Weinreich Reflex regulation of airway sympathetic nerves in guinea-pigs J. Physiol., June 1, 2006; 573(2): 549 - 564. [Abstract] [Full Text] [PDF]

				S. Andreas, C. Herrmann-Lingen, T. Raupach, L. Luthje, J. A. Fabricius, N. Hruska, W. Korber, B. Buchner, C-P. Criee, G. Hasenfuss, et al. Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial Eur. Respir. J., May 1, 2006; 27(5): 972 - 979. [Abstract] [Full Text] [PDF]

				C. Unterberg, L. Luthje, J. Szych, D. Vollmann, G. Hasenfuss, and S. Andreas Atrial overdrive pacing compared to CPAP in patients with obstructive sleep apnoea syndrome Eur. Heart J., December 1, 2005; 26(23): 2568 - 2575. [Abstract] [Full Text] [PDF]

				S. Andreas, S. D. Anker, P. D. Scanlon, and V. K. Somers Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease Chest, November 1, 2005; 128(5): 3618 - 3624. [Abstract] [Full Text] [PDF]

				L. Luthje, C. Unterberg-Buchwald, D. Dajani, D. Vollmann, G. Hasenfuss, and S. Andreas Atrial Overdrive Pacing in Patients with Sleep Apnea with Implanted Pacemaker Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 118 - 122. [Abstract] [Full Text] [PDF]

				A. Ciarka, B. Najem, N. Cuylits, M. Leeman, O. Xhaet, K. Narkiewicz, M. Antoine, J.-P. Degaute, and P. van de Borne Effects of Peripheral Chemoreceptors Deactivation on Sympathetic Activity in Heart Transplant Recipients Hypertension, May 1, 2005; 45(5): 894 - 900. [Abstract] [Full Text] [PDF]

				S. Andreas, H. Reiter, L. Luthje, A. Delekat, R. W. Grunewald, G. Hasenfuss, and V. K. Somers Differential Effects of Theophylline on Sympathetic Excitation, Hemodynamics, and Breathing in Congestive Heart Failure Circulation, October 12, 2004; 110(15): 2157 - 2162. [Abstract] [Full Text] [PDF]

				S. Velez-Roa, A. Ciarka, B. Najem, J.-L. Vachiery, R. Naeije, and P. van de Borne Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension Circulation, September 7, 2004; 110(10): 1308 - 1312. [Abstract] [Full Text] [PDF]

				L. W. Raymond Vagal Pas de Deux: Heart-Lung Interplay in Postexercise Heart Rate Recovery Chest, April 1, 2004; 125(4): 1186 - 1190. [Full Text] [PDF]

				D. D. Sin and S.F. P. Man Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?: The Potential Role of Systemic Inflammation in Chronic Obstructive Pulmonary Disease Circulation, March 25, 2003; 107(11): 1514 - 1519. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662. [Full Text] [PDF]